IP Library Granted Patent US 8,008,037
Granted Patent B2
US 8,008,037 · App. 12/056,473 · Granted Aug 30, 2011

Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,008,037
App. No.
12/056,473
Granted
Aug 30, 2011
Kind
B2
Abstract

A chemistry matrix for use in determining the concentration of an analyte in a biological fluid includes a glucose dehydrogenase, nicotinamide adenine dinucleotide, an alkylphenazine quaternary salt, and/or a nitrosoaniline. The chemistry matrix is used with an electrochemical biosensor to determine the concentration of an analyte after a reaction occurs within the biosensor, at which time an analysis is completed to determine the concentration. A method of determining the concentration of an analyte using the chemistry matrix of glucose dehydrogenase, nicotinamide adenine dinucleotide, an alkylphenazine quaternary salt, and/or a nitrosoaniline is another aspect that is described. The method also further features test times of five seconds or less. Methods utilizing the new chemistry matrix can readily determine an analyte such as blood glucose at concentrations of from about 20-600 mg/dL at a pH of from about 6.5 to about 8.5.

Claims (52)

1. A chemistry matrix composition for use in determining the concentration of an analyte with reduced interference from other constituents present with the analyte, the matrix comprising glucose dehydrogenase, nicotinamide adenine dinucleotide, a 5-alkylphenazine quaternary salt, and a nitrosoaniline, wherein said matrix is stable at a pH of from about 6.5 to about 8.5 and is photochemically stable.

2. The composition of claim 1 , wherein the 5-alkylphenazine quaternary salt is a compound having the formula:

where:

Z is selected from the group consisting of —(CH 2 ) m COOH, —NHAc, and —OY,

where m can any integer ranging from 0 to about 6 and Y is selected from the group consisting of

where n is an integer ranging from about 1 to about 4, Q is —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) o NR 2 R 3 , —NH(CH 2 ) o OH, —NHCH 2 CH 2 —(OCH 2 CH 2 ) o -G, —(CH 2 ) o NR 2 R 3 , —OCH 2 CH 2 ) o NR 2 R 3 or —(OCH 2 CH 2 ) o OH, where G is —COOH, NR 2 R 3 , or

R 1 is a C 1 to C 6 alkyl group, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, o is an integer ranging from about 1 to about 6; and X is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO − , CH 3 OSO 2 − , C 2 H 5 OSO 2 − , and CH 3 SO 3 − .

3. The composition of claim 1 , wherein the nitrosoaniline is a compound having the formula:

and,

R 10 denotes hydrogen, halogen, alkoxy or alkylthio,

R 11 represents an alkyl or a hydroxyalkyl residue and

R 12 represents a hydroxyalkyl residue or

R 11 and R 12 are the same or different and each represents a

dialkylaminoalkyl residue, a hydroxyalkyl, a hydroxyalkoxyalkyl or alkoxyalkyl residue, or

R 11 and R 12 form an alkylene residue interrupted by sulphur, nitrogen, or a substituted nitrogen residue, or

provided if R 10 is in the ortho position to NR 10 R 11 , R 11 also together with R 10 represents an alkylene residue wherein R 12 then represents a hydroxyalkyl residue or,

R 10 and R 12 are the same or different and each represents a hydroxyalkyl residue or a salt thereof.

4. The chemistry matrix of claim 2 , wherein R 1 is C 2 H 5 .

5. The chemistry matrix of claim 4 , wherein said nitrosoaniline has the formula:

6. The chemistry matrix composition of claim 5 , wherein Z is —OY; Y is —(CH 2 ) n COOQ; Q is OH; and n=3.

7. The chemistry matrix composition of claim 5 , wherein Z is —OY; Y is —(CH 2 ) n COOQ; Q is —NHCH 2 CH 2 —(OCH 2 CH 2 ) o - G; G is —COOH; and o is 4.

8. The chemistry matrix composition of claim 5 , wherein Z is —OY; Y is —(CH 2 ) n Q; Q is —NH 2 and n is 4.

9. The chemistry matrix composition of claim 5 , wherein Z is —OY; Y is —(CH 2 ) n Q; Q is —OH and n is 3.

10. The chemistry matrix composition of claim 5 , wherein Z is —OY; Y is —(CH 2 ) n Q; Q is —OR 2 ; R 2 is Me; and n is 4.

11. The chemistry matrix composition of claim 5 , wherein Z is —(CH 2 ) m COOH and m is 1.

12. The chemistry matrix composition of claim 5 , wherein Z is —NHAc.

13. A chemistry matrix composition for use in analyzing the concentration of an analyte with reduced interference from other constituents present with the analyte, the composition comprising glucose dehydrogenase; nicotinamide adenine dinucleotide; a nitrosoaniline and a 5-alkylphenazine quaternary salt having the formula:

where R 6 is selected from the group consisting of —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) m NR 2 , —NH(CH 2 ) m OH, —O(CH 2 ) m NH 2 , and —O(CH 2 ) m OH, R 1 is a C 1 to C 6 alkyl group, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, X − is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO − , CH 3 OSO 2 − , C 2 H 5 OSO 2 − , and CH 3 SO 3 − , and n and m are integers ranging from about 1 to about 6.

14. The chemistry matrix of claim 13 , wherein R 1 is C 2 H 5 .

15. The chemistry matrix of claim 14 , wherein said nitrosoaniline has the formula:

and,

R 10 denotes hydrogen, halogen, alkoxy or alkylthio,

R 11 represents an alkyl or a hydroxyalkyl residue and

R 12 represents a hydroxyalkyl residue or

R 11 and R 12 are the same or different and each represents a dialkylaminoalkyl residue, a hydroxyalkyl, a hydroxyalkoxyalkyl or alkoxyalkyl residue, or

R 11 and R 12 form an alkylene residue interrupted by sulphur, nitrogen, or a substituted nitrogen residue, or

provided if R 10 is in the ortho position to NR 10 OR 11 , R 11 also together with R 10 represents an alkylene residue wherein R 12 then represents a hydroxyalkyl residue or,

R 10 and R 12 are the same or different and each represents a hydroxyalkyl residue or a salt thereof.

16. The chemistry matrix of claim 15 , wherein said nitrosoaniline has the formula:

17. A chemistry matrix composition for use in analyzing the concentration of an analyte, comprising glucose dehydrogenase, nicotinamide adenine dinucleotide, a nitrosoaniline precursor and a photochemically stable 1-carboxyalkyloxy-5-alkylphenazine useful for determining the concentration of an analyte.

18. The chemistry matrix of claim 17 , wherein the nitrosoaniline has the formula:

wherein,

R 10 denotes hydrogen, halogen, alkoxy or alkylthio,

R 11 represents an alkyl or a hydroxyalkyl residue and R 12 represents a Hydroxyalkyl residue or

R 11 and R 12 are the same or different and each represents a dialkylaminoalkyl residue, a hydroxyalkyl, a hydroxyalkoxyalkyl or alkoxyalkyl residue, or

R 11 and R 12 form an alkylene residue interrupted by sulphur, nitrogen, or a substituted nitrogen residue, or

provided if R 10 is in the ortho position to NR 11 R 12 , R 11 also together with R 10 represents an alkylene residue wherein R 12 then represents a hydroxyalkyl residue.

19. The chemistry matrix of claim 18 , wherein the 5-alkyl-1-carboxyalkyloxyphenazine is a compound having the formula:

wherein where R 6 is selected from the group consisting of —OH, —OR 1 , —NH 2 , —NHR 2 , —NR 2 R 3 , —NH(CH 2 ) m NR 2 , —NH(CH 2 ) m OH, —O(CH 2 ) m NH 2 , and —O(CH 2 ) m OH, R 2 is a C 1 to C 6 alkyl group, R 1 is C 1 to C 6 alkyl, R 2 and R 3 are the same or different and each represents a H or a C 1 to C 6 alkyl group, X − is an anion selected from the group consisting of halide, sulfate, alkyl sulfate, phosphate, phosphite, carboxylate, CF 3 COO − , CH 3 OSO 2 − , C 2 H 5 OSO 2 − , and CH 3 SO 3 − , and n and m are integers ranging from about 1 to about 6.

20. The chemistry matrix composition of claim 1 for use in an electrochemical process for determining the concentration of an analyte with reduced interference from other constituents present with the analyte.

21. The chemistry matrix composition of claim 20 in which the 5-alkylphenazine quaternary salt is a 5-ethylphenazine salt.

22. The chemistry matrix composition of claim 21 in which the 5-ethylphenazine salt is 1-(3-carboxypropyloxy)-5-ethylphenazine.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE PREVIOUSLY RECORDED ON REEL 020877 FRAME 0666. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Dec 4, 2008
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 022103/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2008
From: WIEDER, HERBERT
To: ROCHE DIAGNOSTICS GMBH
Reel/Frame 020877/0628 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2008
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 020877/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 30, 2008
From: WILSEY, CHRISTOPHER D.; GHOSHAL, MITALI
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 020877/0687 →